Atkinson v. Lammico Insurance Co.

63 So. 3d 1176, 11 La.App. 3 Cir. 13, 2011 La. App. LEXIS 525, 2011 WL 1661527
CourtLouisiana Court of Appeal
DecidedMay 4, 2011
Docket11-13
StatusPublished
Cited by2 cases

This text of 63 So. 3d 1176 (Atkinson v. Lammico Insurance Co.) is published on Counsel Stack Legal Research, covering Louisiana Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Atkinson v. Lammico Insurance Co., 63 So. 3d 1176, 11 La.App. 3 Cir. 13, 2011 La. App. LEXIS 525, 2011 WL 1661527 (La. Ct. App. 2011).

Opinion

AMY, Judge.

_J_¡The plaintiffs filed suit, alleging that their minor child suffered .damages as a result of a physician’s failure to test his brother for a genetic disorder. The defendants filed an exception of prematurity, arguing that the plaintiffs had failed to exhaust the remedies available in the Louisiana Medical Malpractice Act (MMA) pri- or to the institution of suit. The trial court determined that the child was a “patient” for the purposes of the MMA and granted the exception. The intervenor, the Louisiana Patient’s Compensation Fund Oversight Board, appeals, asserting that the trial court erred in granting the exception. For the following reasons, we reverse the trial court’s grant of the exception of prematurity and remand for further proceedings.

Factual and Procedural Background

This suit arises from allegations that one of the defendants, Dr. Martin C. Young, committed medical malpractice. The basic facts of this case are not in dispute. Mickey and Amy Atkinson consulted Dr. Young for treatment of their son Gabriel’s deep-skin pigmentation condition. Dr. Young diagnosed Gabriel with idiopathic Addison’s Disease, but did not test him to determine the cause of the disease.

After Gabriel’s condition did not improve, the Atkinsons sought a second opinion from Dr. Janna Flint. Dr. Flint had Gabriel tested for a rare and potentially fatal cause of idiopathic Addison’s Disease-X-linked Adrenoleukodystrophy (“X-ALD”). According to the parties’ arguments at the hearing on the exception of prematurity, X-ALD is a genetic disorder that, if left untreated, results in coma and/or death by age thirteen. Gabriel tested positive for X-ALD. Because X-ALD is an X-linked genetic disorder, Dr. Flint “immediately recommended” that the Atkinsons’ | gother sons, Evan and Luke, be tested for the disease. The youngest son, Luke, tested positive.

The Atkinsons, individually and on behalf of Gabriel, Evan, and Luke, sued Dr. Young and his insurance companies, seeking damages for Dr. Young’s alleged failure to test Luke for X-ALD. 1 The defendants filed a dilatory exception of prematurity, arguing that a medical review panel had not reviewed the plaintiffs’ *1179 claim before they filed suit. The Louisiana Patient’s Compensation Fund Oversight Board (the Oversight Board) intervened, 2 asserting that Luke was not a “patient” within the meaning of the MMA and that, therefore, the claim was not subject to review by a medical review panel.

After a hearing, the trial court found that “through Gabriel, Luke was also a patient” of Dr. Young and granted the exception. The Oversight Board appeals, asserting the following assignments of error:

1. Contrary to the clear allegation in the plaintiffs’ Panel Request, that Dr. Young never had a physician/patient relationship with Master Luke, which Panel Request was admitted into evidence by the plaintiffs with no contrary documentary evidence or testimony to contradict such allegation, the Trial Court erred in factually determining that Luke was a patient of Dr. Young.
2. The Trial Court erred in granting Dr. Young’s Exception of Prematurity, where the definition of “malpractice” under the MMA requires a physician/patient relationship and the undercontroverted evidence indicated that there was no 13physician/patient relationship between Dr. Young and Master Luke.

Discussion

The Louisiana Medical Malpractice Act (MMA)

Louisiana Revised Statutes 40:1299.41 through 40:1299.49 sets forth the MMA, which limits liability for “qualified health care providers” and provides a procedural framework for the litigation of medical malpractice claims. See Delcambre v. Blood Systems, Inc., 04-561 (La.1/19/05), 893 So.2d 23. The MMA’s procedural requirements and limitations of liability apply only to medical malpractice claims. Id. All other tort liability by a qualified health care provider is subject to the general law of torts. Id. We note that, because the provisions of the MMA are in derogation of the rights of tort victims, the act is strictly construed. Blevins v. Hamilton Med. Ctr., Inc., 07-127 (La.6/29/07), 959 So.2d 440.

One of the primary features of the MMA is that, when a plaintiff asserts a claim meeting the statutory requirements, unless the parties agree to waive the requirement, the plaintiff must submit his complaint to a medical review panel and may not file suit in any court until the medical review panel has rendered its expert opinion on the merits of the complaint. Delcambre, 893 So.2d 23. Thus, if the plaintiff fails to submit the claim to a medical review panel before the institution of suit, the appropriate procedural remedy is a timely filed exception of prematurity. Blevins, 959 So.2d 440.

At the hearing on an exception of prematurity, “evidence may be introduced to support or controyert any of the objections pleaded, when the grounds thereof do not appear from the petition.” La.Code Civ.P. art. 930. “The burden of proving prematurity is on the exceptor ... who must show that it is entitled to a medical Preview panel because the allegations fall *1180 within the [MMA].” Blevins, 959 So.2d at 444.

“Malpractice,” as defined by the MMA, is:

any unintentional tort or any breach of contract based on health care or professional services rendered, or which should have been rendered, by a health care provider, to a patient, including failure to render services timely and the handling of a patient, including loading and unloading of a patient, and also includes all legal responsibility of a health care provider arising from acts or omissions during the procurement of blood or blood components, in the training or supervision of health care providers, or from defects in blood, tissue, transplants, drugs, and medicines, or from defects in or failures of prosthetic devices implanted in or used on or in the person of a patient.

La.R.S. 40:1299.41(A)(13) (emphasis added).

The MMA defines a “patient” as “a natural person, including a donor of human blood or blood components and a nursing home resident who receives or should have received health care from a licensed health care provider, under contract, expressed or implied.” La.R.S. 40:1299.41(A)(15) (emphasis added). Further, “health care” is defined as “any act or treatment performed or furnished, or which should have been performed or furnished, by any health care provider for, to, or on behalf of a patient during the patient’s medical care, treatment, or confinement, or during or relating to or in connection with the procurement of human blood or blood components.” La.R.S. 40:1299.41(A)(9) (emphasis added).

In Coleman v. Deno, 01-1517 (La.1/25/02), 813 So.2d 303, the supreme court enumerated a list of factors to be considered in determining whether alleged misconduct by a qualified health care provider constitutes “malpractice” under the MMA.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

W.P. v. Universal Health Services Foundation
91 So. 3d 1097 (Louisiana Court of Appeal, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
63 So. 3d 1176, 11 La.App. 3 Cir. 13, 2011 La. App. LEXIS 525, 2011 WL 1661527, Counsel Stack Legal Research, https://law.counselstack.com/opinion/atkinson-v-lammico-insurance-co-lactapp-2011.